A substance used as a therapy for Parkinson's Disease; the L form of Dopa; L-dihydroxyphenylalanine; L-hydroxytyrosine (C9H11NO4); also called L-dopa. In the body it is converted by the enzyme dopa-decarboxylase into dopamine, the form in which it is active in the brain, affecting neural impulse transmission.
A drug, containing a form of the important brain chemical dopamine, commonly used to treat symptoms of Parkinson's disease. Sinemet and Prolopa contain levodopa.
a prescription drug used to treat the symptoms of Parkinson's disease.
Levodopa was the first major breakthrough in the treatment of Parkinson's disease. Levodopa is used by the brain to produce the chemical dopamine, which is deficient in persons with PD. The neurotransmitter is converted by the neurons in the brain into dopamine, which is stored within the cells until needed by the body.
an effective anti-Parkinson drug, that is changed into dopamine in the brain.
is changed into dopamine in the brain - a drug.
Dopamine precursor. Used in the treatment of Parkinson’s disease to compensate for the lack of dopamine.
The international generic name for the medicinal formulation of L-Dopa. It is contained in Sinemet and Prolopa.
the levorotatory form of dopa (trade names Bendopa and Brocadopa and Larodopa); as a drug it is used to treat Parkinson's disease
The main medication used to treat PD. It is converted to dopamine (the chemical messenger which is deficient in someone with Parkinson's disease), when it reaches the brain.
Used to treat Parkinson's disease and other neurological movement disorders, like dystonia and essential tremor.
A natural amino acid that the brain converts into dopamine. Drugs containing levodopa, such as co-careldopa (Sinemet) and co-beneldopa (Madopar), are used to treat Parkinson's.
The international generic name for the medicinal formulation of L-Dopa. It is contained in Sinemet. A precursor of dopamine which is converted to dopamine in the brain.
the single most effective anti-Parkinson drug; it is changed into dopamine in the brain.
A precursor of dopamine which is converted to dopamine in the brain. Levodopa is currently the treatment of choice for PD and is a constituent of Sinemet® and Madopar
antiparkinson drug which is changed into dopamine in the brain; usually combined with carbidopa i.e. Sinemet).
The chemical precursor to dopamine in the brain; also the most common and most effective agent for managing symptoms of Parkinson's disease.
The generic name for the main medication used for the treatment of Parkinson's disease. Sinemet® is a common brand name for levodopa that is familiar to many patients with Parkinson's disease. (Sinemet is a registered trademark of Merck & Co., Inc.)
Used in treating PD, levodopa is converted to dopamine, which is a key chemical messenger in the brain responsible for smooth, coordinated movement and other motor and cognitive functions
converted to dopamine in the brain, and is used in treating Parkinson's disease; also called L-dopa
Also called L-dopa, it is the most commonly administered drug to treat Parkinson's symptoms (its brand name is Sinemet in the United States). Levodopa helps restore levels of dopamine, a chemical messenger in the brain responsible for smooth, coordinated movement and other motor and cognitive functions.
Levodopa (INN) or L-DOPA (3,4-dihydroxy-L-phenylalanine) is an intermediate in dopamine biosynthesis. Clinically, levodopa is used in the management of Parkinson's disease. Biologically, it is a component in marine adhesives used by pelagic life.